An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. [electronic resource]
- Psychopharmacology Jan 2014
- 1-11 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1432-2072
10.1007/s00213-013-3364-6 doi
Antidepressive Agents, Second-Generation--therapeutic use Benzazepines--therapeutic use Bupropion--therapeutic use Clinical Trials, Phase II as Topic--methods Cross-Over Studies Drug Evaluation, Preclinical Feasibility Studies Humans Quinoxalines--therapeutic use Research Design Smoking Cessation--methods Validation Studies as Topic Varenicline